New York—Pharmaceutical company GlaxoSmithKline is in talks with media agencies about a possible review of its estimated $1.6 billion global media account, according to Advertising Age, a sibling publication of BtoB.

The media account is now handled by multiple agencies globally. According to sources familiar with the situation, GlaxoSmithKline is conferring with agencies before opening a formal review.